The impact of oncogenic signalling on cancer metabolomics
- Prosjektnummer
- 46056613
- Ansvarlig person
- Saurabh Sayajirao Gorad
- Institusjon
- NTNU, ISB
- Prosjektkategori
- phd-stipend 2012
- Helsekategori
- Cancer
- Forskningsaktivitet
- 5. Treatment Developement
Identification of Metastasis-Associated Metabolic Profiles of Tumors by (1)H-HR-MAS-MRS.
Neoplasia 2015 Oct;17(10):767-75.
PMID: 26585232 - Inngår i doktorgradsavhandlingen
Metabolic reprogramming supports the invasive phenotype in malignant melanoma.
Cancer Lett 2015 Sep 28;366(1):71-83. Epub 2015 jun 18
PMID: 26095603 - Inngår i doktorgradsavhandlingen
Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer.
Breast Cancer Res 2013 Feb 28;15(1):R16. Epub 2013 feb 28
PMID: 23448424
Inhibition of O-GlcNAc transferase activity reprograms prostate cancer cell metabolism.
Oncotarget 2015 [In Press] doi: 10.18632/oncotarget.7039
Metabolic profile of primary tumors predict lymph node metastasis in a melanoma xenograft model
ESMRMB 2013 [Abstract, oral presentation]
Evaluation of metabolic biomarkers associated to PI3K inhibition in breast cancer xenografts using HR MAS MRS
Abstract, MedIm National PhD Conference 2012
The impact of oncogenic signaling on the metabolomics of melanoma and prostate cancer
- Disputert:
- desember 2015
- Hovedveileder:
- Siver Andreas Moestue
- Saurabh Sayajirao Gorad Doktorgradsstipendiat
- Saurabh Sayajirao Gorad Doktorgradsstipendiat
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Helse Midt-Norge RHF - Samarbeidsorganet og FFU